Translational Software exhibiting at ASHG2017 Booth 400 October 17-21, 2017.
Understanding a patient’s unique genetic makeup can allow a clinician to select a medication with fewer side effects and optimize therapeutic strategies. Using Translational Software®’s platform, a clinician can also assess disease risk profiles, and narrowly target cancer treatments.
Providers face daunting challenges in working to realize the promise of precision medicine:
- Genetic results are complex
- Information infrastructure is young
- Science and tools are advancing rapidly
Translational Software®’s clinical decision support platform transforms genetic test results into actionable insight that improve patient outcomes.
Our expert knowledge curators and cloud-based technology provide the latest scientific advances to labs and clinics without adding IT infrastructure.
Today we provide actionable information for pharmacogenomics, carrier screening and wellness. Since 2013 more than 20 thousand clinicians have received over 1 million support recommendations.
How We Translate
When a clinician orders a genetic test from the lab of her choice, the lab runs the test and submits patient information and raw genetic data to Translational Software® for reporting. Our proprietary knowledge platform generates a tailored, clinically meaningful report. The lab reviews, approves and releases the report to the physician, who uses it to enhance patient treatment.
This process enables timely, cost-efficient delivery of results in a form accessible and useful to healthcare providers and patients.
Actionable. Reports highlight results critical for patient care. [Examples]
Concise. Priority information is highlighted so you don’t have to hunt.
Decision-ready. Visual decision-making aids help you weight trade-offs.
Tailored. Reports are customized to the recipient based on their clinical context (e.g. cardiologist, psychiatrist, pain clinic, etc.)
Knowledge base. Our experts keep pace with the flood of new discoveries so that your team can focus on patients, not evidence curation.
Not only do Translational Software® experts compile the latest scientific consensus and implications for care, they help shape them, as members of international review boards for genetic evidence.
Knowledge platform. Through our web-based portal, HL7 messages using LOINC coding or via our API built on the Fast Healthcare Interoperability Resources (FHIR®) standard, our technology fills gaps in your infrastructure, enabling molecular decision support without major investment in new systems or disrupting data flows.
Who We Serve
How We Are Unique
Evidence Based. We deliver decision support based on the clinical guidance of expert groups, evidence levels are transparent and clearly surfaced.
Accessible. We deliver expert knowledge in a concise form at affordable prices.
Integrated. We speak FHIR®, LOINC and HL7 to deliver the information you need in the context you need.
Facilitate interoperability. API is built on the Fast Healthcare Interoperability Resources (FHIR®) standard that is RESTful and uses OAuth.
Multilingual. Reports can be delivered in the language of your choice.